In this article, we are going to take a look at where Sarepta Therapeutics, Inc. (NASDAQ:SRPT) stands against the other healthcare stocks. McKinsey reported that, since 2019, the US healthcare ...
Read Our Latest Stock Report on SRPT Sarepta Therapeutics Stock Down 0.3 % Shares of NASDAQ SRPT opened at $111.82 on Thursday. Sarepta Therapeutics has a 1 year low of $102.15 and a 1 year high ...
Ingram brings extensive experience in the biopharmaceutical sector, currently serving as President and CEO of Sarepta since June 2017. His background includes leadership roles at Chase ...
Sarepta's third-quarter results for 2024 exceeded expectations, with total revenue reaching approximately $430 million, surpassing the consensus estimate of $400 million. The company's trailing ...
On Monday, Google said it would update its maps to display Gulf of America as soon as the U.S. government updated its official maps. “We have a longstanding practice of applying name changes ...
In a report released yesterday, Kostas Biliouris from BMO Capital maintained a Buy rating on Sarepta Therapeutics (SRPT – Research Report), with a price target of $200.00. Kostas Biliouris has ...
Google Maps will display the name “Gulf of America” instead of the “Gulf of Mexico” for U.S. users once official government sources are updated to reflect the name change ordered by ...
Google said today that it plans to update Google Maps to reflect President Trump’s January 20th executive order to change the names of the Gulf of Mexico and Denali to the Gulf of America and ...
Google Maps will reflect President Trump’s changes in the United States and will show the Gulf of America and Mount McKinley, Fox News Digital has learned. Google will make the changes once ...
Sarep­ta Ther­a­peu­tics un­veiled new re­sults from the sec­ond part of a clin­i­cal tri­al for its Duchenne mus­cu­lar dy­s­tro­phy gene ther­a­py Ele­v­idys … ...
No new safety signals were observed. As part of a collaboration agreement signed in 2019, Sarepta is working with Roche Holdings AG RHHBY. Sarepta is responsible for regulatory approval and ...